Carcinoid syndrome physical examination: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Carcinoid syndrome}} | {{Carcinoid syndrome}} | ||
{{CMG}} | {{CMG}}{{AE}}{{PSD}} | ||
==Overview== | ==Overview== | ||
Line 16: | Line 15: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] |
Revision as of 18:02, 21 September 2015
Carcinoid syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Carcinoid syndrome physical examination On the Web |
American Roentgen Ray Society Images of Carcinoid syndrome physical examination |
Risk calculators and risk factors for Carcinoid syndrome physical examination |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
A patient may present and verbally identify symptoms such as flushing and diarrhea or may not articulate them at all. During examination, evidence of T.I.P.S. - tricuspid insufficency pulmonic stenosis may appear. In many cases, increased levels of 5-HIAA may be found in urine specimens.